Laman Utama2AB • FRA
add
Barinthus Biotherapeutics PLC - ADR
Tutup sebelumnya
€0.48
Julat tahun
€0.45 - €1.54
Permodalan pasaran
24.26J USD
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | — | — |
Perbelanjaan pengendalian | 4.51J | 180.64% |
Pendapatan bersih | -11.09J | 46.01% |
Margin untung bersih | — | — |
Pendapatan bagi setiap syer | -0.27 | -33.70% |
EBITDA | -4.57J | -336.68% |
Kadar cukai berkesan | 0.51% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 70.46J | -36.33% |
Jumlah aset | 98.17J | -38.77% |
Jumlah liabiliti | 23.88J | -20.92% |
Jumlah ekuiti | 74.29J | — |
Syer tertunggak | 40.85J | — |
Harga kepada buku | 0.26 | — |
Pulangan pada aset | -11.77% | — |
Pulangan pada modal | -13.43% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -11.09J | 46.01% |
Tunai daripada operasi | -4.24J | -132.42% |
Tunai daripada pelaburan | 2.00K | 100.72% |
Tunai daripada pembiayaan | 0.00 | -100.00% |
Perubahan bersih dalam tunai | -3.82J | -160.69% |
Aliran tunai bebas | 2.94J | -80.40% |
Perihal
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
Diasaskan
2016
Tapak web
Pekerja
14
